Journal List > Korean J Pediatr Infect Dis > v.21(1) > 1096030

Choi, Jung, Kim, Chung, Kim, Han, Kang, Kim, Rhim, Kim, Park, Jo, Ma, Jeong, Cheon, Koh, and Kim: Comparison among Known Severity Scoring Scales in the Evaluation of Acute Gastroenteritis in Children

Abstract

Purpose

This study aimed to evaluate the disease severity of children suffering from gastroenteritis using different scales. The results are compared and subsequently classified on the basis of the type of virus causing the disease in order to investigate the differences in clinical characteristics and disease severity according to pathogen.

Method

This study was conducted prospectively with patients under 5 years of age diagnosed with acute gastroenteritis and hospitalized at 9 medical institutions in 8 regions across the Republic of Korea. Disease severity was evaluated using the Vesikari Scale, the Clark Scale, and the modified Flores Scale. Fecal samples collected from patients were used to detect rotavirus and enteric adenovirus by enzyme immunoassay, and for RT-PCR of norovirus, astrovirus, and sapovirus.

Results

There were a total of 214 patients with a male : female ratio of 1.58 : 1, of which 35 were under the age of 6 months (16.4%), 105 were aged 6-23 months (49.1%), and 74 were aged 24-59 months (34.5%). The rate of concordance between the Vesikari and Clark Scales was 0.521 (P<0.001) and, in severe cases, the Vesikari Scale was 60.7% and Clark Scale was 2.3%, indicating that the Clark Scale was stricter in the evaluation of severe cases.

Conclusions

In children with gastroenteritis, there were differences in disease severity based on the scale used. Therefore, to achieve consistent results among researchers, either only a single scale or a measure of all scales should be used to determine disease severity.

Figures and Tables

Fig. 1
Detection status of causative viruses in 214 acute gastroenteritis episodes in admitted children <5 years old.
kjpid-21-43-g001
Table 1
Criteria of Three Gastroenteritis Severity Scoring Systems
kjpid-21-43-i001

Abbreviations: NA, not applicable

*Non-severe (<9); severe (9-14); very severe (≥15)

Mild (<9);moderate (9-16);severe (≥17)

Non-severe(<11); severe(≥11)

Table 2
Comparison of Clinical Scoring Scale between Gender and Age Groups
kjpid-21-43-i002

*Mann-Witney U test

Differences between 6-23 months age group and other two age groups

Table 3
The Relationship between Vesikari and Clark Scoring Scales in 214 Acute Gastroenteritis Episodes in Admitted Children <5 Years Old
kjpid-21-43-i003

Kappa=0.521 (P<0.001)

Table 4
The Relationship between Vesikari and Modified Flores Scoring Scales in 214 Acute Gastroenteritis Episodes in Admitted Children <5 Years Old
kjpid-21-43-i004

Kappa=-0.109 (P<0.001)

Table 5
The Relationship between Clark and Modified Flores Scoring Scales in 214 Acute Gastroenteritis Episodes in Admitted Children <5 Years Old
kjpid-21-43-i005

Kappa=-0.091 (P=0.007)

Table 6
Maximal Number per Day and Duration of Diarrhea and Vomiting According to the Types of Viruses in Admitted Children <5 Years Old with Acute Gastroenteritis
kjpid-21-43-i006
Table 7
Three Severity Scoring Scales According to the Types of Viruses in Admitted Children <5 Years Old with Acute Gastroenteritis
kjpid-21-43-i007

References

1. Boschi-Pinto C, Velebit L, Shibuya K. Estimating child mortality due to diarrhoea in developing countries. Bull World Health Organ. 2008; 86:710–717.
crossref
2. Midthun K, Kapikian AZ. Rotavirus vaccines: an overview. Clin Microbiol Rev. 1996; 9:423–434.
crossref
3. Ahn SE, Lim HC, Kim HM, Uh Y, Seok SW. Comparing the cause and symptom severity of children with acute gastroenteritis. Korean J Pediatr Infect Dis. 2008; 15:138–145.
crossref
4. Bass DM. Rotaviruses, caliciviruses, and astroviruses. In : Kliegman RM, Stanton BF, St. Geme JW, Schor NF, Behrman RE, editors. Nelson Textbook of Pediatrics. 19th ed. Philadelphia: Elsevier Saunders Press;2011. p. 1134–1137.
5. Division of Enteric Viruses and Hepatitis Viruses, Korea Centers for Disease Control and Prevention. Laboratory surveillance of viral acute gastroenteritis, 2005-2008. Public Health Wkly Rep. 2010; 3:90–92.
6. Hall AJ, Rosenthal M, Gregoricus N, Greene SA, Ferguson J, Henao OL, et al. Incidence of acute gastroenteritis and role of norovirus, Georgia, USA, 2004-2005. Emerg Infect Dis. 2011; 17:1381–1388.
crossref
7. Ruuska T, Vesikari T. Rotavirus disease in Finnish children: use of numerical scores for clinical severity of diarrhoeal episodes. Scand J Infect Dis. 1990; 22:259–267.
crossref
8. Clark HF, Borian FE, Bell LM, Modesto K, Gouvea V, Plotkin SA. Protective effect of WC3 vaccine against rotavirus diarrhea in infants during a predominantly serotype 1 rotavirus season. J Infect Dis. 1988; 158:570–577.
crossref
9. Rennels MB, Glass RI, Dennehy PH, Bernstein DI, Pichichero ME, Zito ET, et al. Safety and efficacy of high-dose rhesus-human reassortant rotavirus vaccines-report of the National Multicenter Trial. United States Rotavirus Vaccine Efficacy Group. Pediatrics. 1996; 97:7–13.
10. Ruiz-Palacios GM, Pérez-Schael I, Velázquez FR, Abate H, Breuer T, Clemens SC, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med. 2006; 354:11–22.
crossref
11. Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med. 2006; 354:23–33.
crossref
12. Givon-Lavi N, Greenberg D, Dagan R. Comparison between two severity scoring scales commonly uses in the evaluation of rotavirus gastroenteritis in children. Vaccine. 2008; 26:5798–5801.
crossref
13. Reisinger KS, Block SL. Characteristics of an ideal rotavirus vaccine. Clin Pediatr (Phila). 2008; 47:555–563.
crossref
14. King CK, Glass R, Bresee JS, Duggan C. Managing acute gastroenteritis among children: oral rehydration, maintenance, and nutritional therapy. MMWR Recomm Rep. 2003; 52(RR-16):1–16.
15. El-Radhi AS, Barry W. Thermometry in paediatric practice. Arch Dis Child. 2006; 91:351–356.
crossref
16. Park KS, Jeong HS, Baek KA, Lee CG, Park SM, Park JS, et al. Genetic analysis of norovirus GII. 4 variants circulating in Korea in 2008. Arch Virol. 2010; 155:635–641.
crossref
17. Jeong AY, Jeong HS, Jo MY, Jung SY, Lee MS, Lee JS, et al. Molecular epidemiology and genetic diversity of human astrovirus in South Korea from 2002 to 2007. Clin Microbiol Infect. 2011; 17:404–408.
crossref
18. Park SH, Kim EJ, Oh SA, Kim CK, Choi SS, Cho SJ, et al. Viral agents associated with acute gastroenteritis in Seoul, Korea. Clin Lab. 2011; 57:59–65.
19. Lewis KD, Dallas MJ, Victor JC, Ciarlet M, Mast TC, Ji M, et al. Comparison of two clinical severity scoring systems in two multi-center, developing country rotavirus vaccine trials in Africa and Asia. Vaccine. 2012; 30:Suppl 1 . A159–A166.
crossref
20. Infectious diseases. In : Ahn HS, editor. Hong CE's textbook of pediatrics. 10th ed. Seoul: Mirae-N Co.;2012. p. 470–472.
21. Zhang S, Chen TH, Wang J, Dong C, Pan J, Moe C, et al. Symptomatic and asymptomatic infections of rotavirus, norovirus, and adenovirus among hospitalized children in Xian, China. J Med Virol. 2011; 83:1476–1484.
crossref
22. Nakanishi K, Tsugawa T, Honma S, Nakata S, Tatsumi M, Yoto Y, et al. Detection of enteric viruses in rectal swabs from children with acute gastroenteritis attending the pediatric outpatient clinics in Sapporo, Japan. J Clin Virol. 2009; 46:94–97.
crossref
23. Wiegering V, Kaiser J, Tappe D, Weissbrich B, Morbach H, Girschick HJ. Gastroenteritis in childhood: a retrospective study of 650 hospitalized pediatric patients. Int J Infect Dis. 2011; 15:e401–e407.
crossref
TOOLS
Similar articles